Who are Folliculinum 30C's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/folliculinum-30c.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Folliculinum 30C — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Folliculinum 30C (Folliculinum 30C) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Reproductive Health / Endocrinology (homeopathic).

phase 3 Reproductive Health / Endocrinology (homeopathic) Small molecule Live · refreshed every 30 min

Target snapshot

Folliculinum 30C (Folliculinum 30C) — Shaare Zedek Medical Center. Folliculinum 30C is a homeopathic preparation derived from follicle-stimulating hormone (FSH) intended to modulate hormonal balance, particularly in reproductive and endocrine contexts.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Folliculinum 30C TARGET	Folliculinum 30C	Shaare Zedek Medical Center	phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Folliculinum 30C — Competitive Intelligence Brief. https://druglandscape.com/ci/folliculinum-30c. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing